NexMed Announces Pre-Clinical Study Showing Vitaros(R) Significantly Promotes Wound Healing
Links shared publicly online about this topic.
- 1,169total visits
NexMed Announces Pre-Clinical Study Showing Vitaros(R) Significantly Promotes Wound Healing
NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products based on the NexACT® technology, announced results from a pre-clinical study showing that Vitaros®, the Company's N
View full resource at medicalnewstoday.com
Most Recently Shared on May 14, 2010 at 12:06 pm By:
NexMed Announces Pre-Clinical Study Showing Vitaros(R) Significantly Promotes Wound Healing http://mnt.to/3CBf #erectiledysfunction
Advertisement
